Nicholas Investment Partners LP Sells 8,920 Shares of Astera Labs, Inc. $ALAB

Nicholas Investment Partners LP cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 16.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 45,251 shares of the company’s stock after selling 8,920 shares during the period. Nicholas Investment Partners LP’s holdings in Astera Labs were worth $7,528,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Eurizon Capital SGR S.p.A. acquired a new stake in Astera Labs in the fourth quarter valued at approximately $18,708,000. Nordea Investment Management AB acquired a new stake in Astera Labs in the fourth quarter valued at approximately $2,028,000. Geneva Partners LLC acquired a new stake in Astera Labs in the third quarter valued at approximately $1,876,000. Numerai GP LLC boosted its stake in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares in the last quarter. Finally, Swedbank AB boosted its stake in Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Down 0.1%

NASDAQ:ALAB opened at $367.15 on Friday. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $390.99. The firm has a fifty day simple moving average of $237.17 and a 200-day simple moving average of $178.94. The company has a market capitalization of $62.93 billion, a P/E ratio of 248.07, a PEG ratio of 4.86 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the firm posted $0.33 earnings per share. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the completion of the transaction, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This trade represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,321,256 shares of company stock valued at $480,893,146. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on ALAB shares. TD Cowen raised their target price on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada raised their target price on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Morgan Stanley raised their target price on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Finally, Needham & Company LLC raised their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.